Kite Pharma Inc., of Los Angeles, named Keith Nolop chief medical officer...Verastem Inc., of Cambridge, Mass., named Robert Forrester president and CEO and Christoph Westphal executive chairman, effective July 1
Edimer Pharmaceuticals Inc., of Cambridge, Mass., added William Aliski and Wendy L. Dixon to its board...Zosano Pharma Inc., of Fremont, Calif., named Nandan Oza chief operations officer
Astellas Pharma Inc., of Tokyo, named Songlin Xue head of global pharmacovigilance, and he will be based in the Northbrook, Ill., office...Zosano Pharma Inc., of Fremont, Calif., named Chris Krueger chief business officer and added Kleanthis G. Xanthopoulos to its board
Bach Pharma Inc., of North Andover, Mass., named William S. Lynn director emeritus...EntreMed Inc., of Rockville, Md., appointed Ken K. Ren CEO, and added James Huang and Y. Alexander Wu to its board
MEI Pharma Inc., of San Diego, named Christine A. White acting lead director of its board...Protea Biosciences Inc., of Morgantown, W. Va., added Thijs Spoor and Josiah T. Austin to its board
Rexahn Pharmaceuticals Inc., of Rockville, Md., named Peter D. Suzdak CEO and Chang AHN chief scientist...Tranzyme Pharma Inc., of Research Triangle Park, N.C., appointed David S. Moore chief business officer
A.P. Pharma Inc., of Redwood City, Calif., appointed Thomas Pitler vice president of business development...Islet Sciences Inc., of New York, added Kevan Herold and Morton Printz to its scientific advisory board
he will chair the audit committee and serve on the compensation committee...Astellas Pharma Europe Ltd., part of Astellas Pharma Inc., of Tokyo, appointed Susan Wood senior director, Market Access
A.P. Pharma Inc., of Redwood City, Calif., added Robert Rosen to its board...Genmus Pharma Inc., of San Francisco, added Christopher Dunn, Louis Miller Jr
Tris Pharma Inc., of Monmouth Junction, N.J., named Amanda Wohlleber vice president of scale-up and technical services and Rajul Parikh vice president, operations
Horizon Pharma Inc., of Deerfield, Ill., appointed Gino Santini to its board...Novavax Inc., of Rockville, Md., named John Hermann vice president and general counsel
and added Eunan Maguire senior vice president of strategy and corporate development...Niiki Pharma Inc., of Hoboken, N.J., formed a scientific advisory board chaired by Daniel Haller and including Lee Ellis and Matt Kulke
ATyr Pharma Inc., of San Diego, appointed R. Alan Ezekowitz to its therapeutic advisory board...BioTime Inc., of Alameda, Calif., and its subsidiary, OncoCyte Corp., each appointed Andrew von Eschenbach to their boards
and Jim Rouse as vice president and chief information officer...Tranzyme Pharma Inc., of Research Triangle Park, N.C., appointed Franck Rousseau chief medical officer
Creabilis SA, of Luxembourg, named Alex Leech vice president and head of finance of operations, appointed James Sandy senior vice president and head of development and added Peter Spargo as senior vice president for chemistry, manufacturing and controls...Tranzyme Pharma Inc., of Research Triangle Park, N.C., added Brent Bankosky as vice president of business development
Kite Pharma Inc., of Los Angeles, named Keith Nolop chief medical officer...Verastem Inc., of Cambridge, Mass., named Robert Forrester president and CEO and Christoph Westphal executive chairman, effective July 1